Mostrar el registro sencillo del ítem

dc.contributor.author
Ajayi, Ebenezer Idowu O  
dc.contributor.author
Fadiya, Oluwadamilola Victoria  
dc.contributor.author
Atanda, Joy Adeyemi  
dc.contributor.author
Muhibi, Musa Abidemi  
dc.contributor.author
Adeleke, M. A.  
dc.date.available
2022-03-31T10:37:50Z  
dc.date.issued
2019  
dc.identifier.citation
Comparative seroepidemiological surveillance of visceral leishmaniasis and its association with diabetes co-morbidity in Osun State, Nigeria; 23rd European Congress of Clinical Chemistry and Laboratory Medicine; Barcelona; España; 2019; 1-2  
dc.identifier.issn
0009-8981  
dc.identifier.uri
http://hdl.handle.net/11336/154094  
dc.description.abstract
Visceral leishmaniasis is the most severe form of leishmaniasis and the second largest parasitic killer in the world after malaria. This sero-epidemiology surveillance was carried out to ascertain visceral leishmaniasis incidence in Osun State, Southwestern Nigeria. Methods A total of 272 volunteers from different towns of the State were enrolled for participation in this study. They were grouped viz.: Control, Diabetic, Diabetic Foot Ulcer in order to investigate the incidence of VL and the association of the disease co-morbidity with diabetes viz-a-viz implication on biochemical parameters of kidney (Urea and Creatinine) and liver (ALT and AST) functions. Using standard protocols of ELISA, Buffy coat and thin film techniques, VL was diagnosed for each volunteer. Results Following screening, the Buffy coat (least recommended) technique did not detect the Leishmania parasite (0%), whereas the thin film examination (sensitivity: 2.3%, specificity: 99.6%, negative predictive value: 84.1%, positive predictive value: 50%) detected 2 (2.1%) while ELISA (the gold standard) detected 44 (16.2%) leishmaniasis cases among the participants. The results revealed statistically significant (p <0.05) decreased urea, increased creatinine, elevated ALT and AST levels in participants found to be infected with Leishmania species compared to those not infected. It is interesting to note that urea, creatinine, ALT and AST levels of participants having a co-morbidity of VL-diabetes and VL-diabetic foot ulcer did not change significantly compared to the Leishmania-infected participants without diabetes or the foot ulcer. Conclusions These findings indicate that Leishmania infection is the singular factor that perturbs the kidney and liver enzymes considered in this study. Therefore VL does not show association with diabetes or diabetic foot ulcer co-morbidity in the population studied. There has not been any reported case of visceral leishmaniasis in Osun State prior to this study. It therefore suffices that the infectious disease has hitherto remained un- or mis-diagnosed. Keywords: Visceral leishmanisis, diabetes, diabetic foot ulcer, kidney function, liver function.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Visceral leishmanisis  
dc.subject
Diabetic foot ulcer  
dc.subject
Urea  
dc.subject
Creatinine  
dc.subject.classification
Otras Ciencias Químicas  
dc.subject.classification
Ciencias Químicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Comparative seroepidemiological surveillance of visceral leishmaniasis and its association with diabetes co-morbidity in Osun State, Nigeria  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/conferenceObject  
dc.type
info:ar-repo/semantics/documento de conferencia  
dc.date.updated
2022-03-16T20:57:36Z  
dc.journal.volume
493  
dc.journal.pagination
1-2  
dc.journal.pais
Bélgica  
dc.journal.ciudad
Gante  
dc.description.fil
Fil: Ajayi, Ebenezer Idowu O. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra. Universidad Nacional de Córdoba. Instituto de Investigación Médica Mercedes y Martín Ferreyra; Argentina  
dc.description.fil
Fil: Fadiya, Oluwadamilola Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Instituto de Investigaciones Biológicas y Tecnológicas. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales. Instituto de Investigaciones Biológicas y Tecnológicas; Argentina  
dc.description.fil
Fil: Atanda, Joy Adeyemi. Osun State University; Nigeria  
dc.description.fil
Fil: Muhibi, Musa Abidemi. Ladoke Akintola University of Technology Teaching Hospital; Nigeria  
dc.description.fil
Fil: Adeleke, M. A.. Osun State University; Nigeria  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0009898119312276  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.cca.2019.03.1122  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.conicet.rol
Autor  
dc.coverage
Internacional  
dc.type.subtype
Congreso  
dc.description.nombreEvento
23rd European Congress of Clinical Chemistry and Laboratory Medicine  
dc.date.evento
2019-05-19  
dc.description.ciudadEvento
Barcelona  
dc.description.paisEvento
España  
dc.type.publicacion
Journal  
dc.description.institucionOrganizadora
International Federation of Clinical Chemistry and Laboratory Medicine  
dc.description.institucionOrganizadora
European Federation of Laboratory Medicine  
dc.description.institucionOrganizadora
Spanish Society of Laboratory Medicine  
dc.source.revista
Clinica Chimica Acta  
dc.date.eventoHasta
2019-05-23  
dc.type
Congreso